5O5B

Poliovirus type 3 (strain Saukett) stabilized virus-like particle


Experimental Data Snapshot

  • Method: ELECTRON MICROSCOPY
  • Resolution: 3.60 Å
  • Aggregation State: PARTICLE 
  • Reconstruction Method: SINGLE PARTICLE 

wwPDB Validation   3D Report Full Report


This is version 1.4 of the entry. See complete history


Literature

Plant-made polio type 3 stabilized VLPs-a candidate synthetic polio vaccine.

Marsian, J.Fox, H.Bahar, M.W.Kotecha, A.Fry, E.E.Stuart, D.I.Macadam, A.J.Rowlands, D.J.Lomonossoff, G.P.

(2017) Nat Commun 8: 245-245

  • DOI: 10.1038/s41467-017-00090-w
  • Primary Citation of Related Structures:  
    5O5P, 5O5B

  • PubMed Abstract: 
  • Poliovirus (PV) is the causative agent of poliomyelitis, a crippling human disease known since antiquity. PV occurs in two distinct antigenic forms, D and C, of which only the D form elicits a robust neutralizing response. Developing a synthetically produced stabilized virus-like particle (sVLP)-based vaccine with D antigenicity, without the drawbacks of current vaccines, will be a major step towards the final eradication of poliovirus ...

    Poliovirus (PV) is the causative agent of poliomyelitis, a crippling human disease known since antiquity. PV occurs in two distinct antigenic forms, D and C, of which only the D form elicits a robust neutralizing response. Developing a synthetically produced stabilized virus-like particle (sVLP)-based vaccine with D antigenicity, without the drawbacks of current vaccines, will be a major step towards the final eradication of poliovirus. Such a sVLP would retain the native antigenic conformation and the repetitive structure of the original virus particle, but lack infectious genomic material. In this study, we report the production of synthetically stabilized PV VLPs in plants. Mice carrying the gene for the human PV receptor are protected from wild-type PV when immunized with the plant-made PV sVLPs. Structural analysis of the stabilized mutant at 3.6 Å resolution by cryo-electron microscopy and single-particle reconstruction reveals a structure almost indistinguishable from wild-type PV3.Despite the success of current vaccination against poliomyelitis, safe, cheap and effective vaccines remain sought for continuing eradication effort. Here the authors use plants to express stabilized virus-like particles of type 3 poliovirus that can induce a protective immune response in mice transgenic for the human poliovirus receptor.


    Organizational Affiliation

    John Innes Centre, Norwich Research Park, Norwich, NR4 7UH, UK. George.Lomonossoff@jic.ac.uk.



Macromolecules
Find similar proteins by:  (by identity cutoff)  |  Structure
Entity ID: 1
MoleculeChainsSequence LengthOrganismDetailsImage
Capsid proteinsA [auth 1]300Human poliovirus 3Mutation(s): 2 
UniProt
Find proteins for Q84895 (Human poliovirus 3)
Explore Q84895 
Go to UniProtKB:  Q84895
Protein Feature View
Expand
  • Reference Sequence
Find similar proteins by:  (by identity cutoff)  |  Structure
Entity ID: 2
MoleculeChainsSequence LengthOrganismDetailsImage
Capsid proteinsB [auth 2]271Human poliovirus 3Mutation(s): 3 
UniProt
Find proteins for Q84895 (Human poliovirus 3)
Explore Q84895 
Go to UniProtKB:  Q84895
Protein Feature View
Expand
  • Reference Sequence
Find similar proteins by:  (by identity cutoff)  |  Structure
Entity ID: 3
MoleculeChainsSequence LengthOrganismDetailsImage
Capsid proteinsC [auth 3]238Human poliovirus 3Mutation(s): 2 
UniProt
Find proteins for Q84895 (Human poliovirus 3)
Explore Q84895 
Go to UniProtKB:  Q84895
Protein Feature View
Expand
  • Reference Sequence
Find similar proteins by:  (by identity cutoff)  |  Structure
Entity ID: 4
MoleculeChainsSequence LengthOrganismDetailsImage
VP4D [auth 4]69Human poliovirus 3Mutation(s): 0 
EC: 3.4.22.29 (PDB Primary Data), 3.6.1.15 (PDB Primary Data), 3.4.22.28 (PDB Primary Data), 2.7.7.48 (PDB Primary Data)
UniProt
Find proteins for P03302 (Poliovirus type 3 (strains P3/Leon/37 and P3/Leon 12A[1]B))
Explore P03302 
Go to UniProtKB:  P03302
Protein Feature View
Expand
  • Reference Sequence
Experimental Data & Validation

Experimental Data

  • Method: ELECTRON MICROSCOPY
  • Resolution: 3.60 Å
  • Aggregation State: PARTICLE 
  • Reconstruction Method: SINGLE PARTICLE 

Structure Validation

View Full Validation Report



Entry History & Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
WHO/Gates foundationUnited KingdomRG.IMCB.I8-TSA-083

Revision History  (Full details and data files)

  • Version 1.0: 2017-07-12
    Type: Initial release
  • Version 1.1: 2017-07-19
    Changes: Source and taxonomy
  • Version 1.2: 2017-08-23
    Changes: Database references
  • Version 1.3: 2017-08-30
    Changes: Refinement description
  • Version 1.4: 2019-10-02
    Changes: Data collection, Other